ADMINISTRATION OF ANTI-TNF ANTIBODY IMPROVES LEFT-VENTRICULAR FUNCTION IN SEPTIC SHOCK PATIENTS - RESULTS OF A PILOT-STUDY
ADMINISTRATION OF ANTI-TNF ANTIBODY IMPROVES LEFT-VENTRICULAR FUNCTION IN SEPTIC SHOCK PATIENTS - RESULTS OF A PILOT-STUDY
复制标题
DOI:
10.1378/chest.101.3.810
复制
发表时间:
1992-03-01
期刊:
影响因子:
9.6
通讯作者:
DUPONT, E
中科院分区:
文献类型:
--
作者:
VINCENT, JL;BAKKER, J;DUPONT, E
In this pilot study, murine monoclonal anti-TNF antibody (2 mg/kg) was administered to ten patients within 24 h of septic shock which persisted after initial resuscitation with intravenous fluids and adrenergic agents. This treatment resulted in a reduction in heart rate (from 122 +/- 10 to 113 +/- 10 beats per minute at 4 h, p < 0.01) associated with an increase in LVSWI (from 26.5 +/- 5.6 to 31.5 +/- 10.5 g.m2 at 2 h, p < 0.05), indicating in the absence of change in cardiac filling pressures, an improvement in ventricular function. Arterial oxygenation improved concurrently in six patients. These changes, however, appeared transient. The improvement in cardiac function following anti-TNF anti-body administration in patients is in keeping with recent experimental studies indicating the role of TNF in the myocardial depression characterizing septic shock.